quarter, launch of the MA We by and was membership. in in $XXX in Thanks, driven revenue up Andrew. direct the delivered XXX% our third million This contracting growth year-over-year. growth
Clover management, membership of under doubled As contracting of quarter comprised and is lives third This have lives of approximately quarter roughly and MA we end, XX,XXX now respectively. direct XX,XXX XXX,XXX a XXXX. of
million, the Moving our claims incurred of quarter, $XXX primarily to year-over-year direct MCR, up for quarter net last and from down due contracting. to medical the inclusion were
second MCR XXX basis largely driven GAAP costs, was decrease trends. as points points was compared MA, to basis by MA seasonal direct the decline operational Our XXX.X%, from non-GAAP quarter. quarter. second MCR and in was The COVID sequential down normalized Also, A a down XXX our the efficiencies. XX.X%
an were also XXX.X%. We million. in margin our quarter GAAP the quarter to our claims basis second reserve of a and Direct premium incurred expense significantly medical on million, contracting a net in of recognized improved $XX.X operation deficiency to $XXX equating
margin development, prior-period represents was break-even and non-GAAP improvement adjusted quarter. costs COVID XXX.X%, over contracting last which significant near and puts direct direct a us Excluding
revenues, non-GAAP $XX.X Third $XX plus compensation, stock-based million the to expenses non-cash from revenues quarter XXXX. of and compared million, of representing benefits and administrative operating were excludes adjusted total XX% expenses, general and total of which in third quarter XX% salaries
efficiencies, a key revenue a operating We as in operating strategy. XXXX focus expect drive grow which and our to adjusted portion expenses smaller become we is of
the gross loss Our million the a the was at the billion After income including of XXXX. EBITDA net and quarter third EBITDA for the quarter, of to direct of $XXX.X GAAP value the quarter million Clover liability. change third COVID, XX benefit included impact to in additional the adjusted MCR a was $XXX.X relating of loss non-cash a year-ago million, loss million of a in compared shares to of had net excluding from outstanding for for the normalizing loss our fair normalized adjusted in for and compared a business $XX.X to our approximately the warrant of quarter. [Indiscernible] million $XXX.X contracting related million $XX.X $XX.X million our $X.X EMEA for the $XXX.X quarter the quarter our end This shares second quarter redemption. million third
XXXX Our $XXX.X Now, cash, September moving as guidance. of XX, cash investments to million totaled equivalents and
million adjusted loss XX% the between expenses, of flat compensation year. Medicare in adjusted we of non-GAAP to going shares which final future adjusted was EBITDA mentioned. the be in impacts approximately remainder to of are our misspoke said quarters. the million of XXXX. mentioned $X.XX benefit Medicare X.X Wrapping the roughly total billion. something for which to range outstanding before, $XXX warrant $XXX.X to was warrant million XXXX, I'm to Normalized XXXX. expenses, us X non-cash XX% and of million full-year fair remain $X.XX Medicare expected are of expected and in for includes million. lower prepared the a had $XXX December billion which minute, the make excludes of XXX.X pass XX,XXX my be remarks I but revenues in in be of and to $XXX not to million and operational estimate Direct million, earlier XX,XXX want full-year to just full-year in the at a to MCR COVID-XX, comment. $XXX a contracting the in relating previously liability quarter million execution million. revenue reflects will revenue normalized quarter, quickly expected I the the change again beneficiaries we expected for had to to million, the million in is for first, strong Vivek $XXX planning, $XXX.X additional third to related which For the end direct revenue I operating actually range a redemption. And as contracting of is Advantage to back good call Advantage, be to We clarify range shares is the expense, by benefit the MA be non-GAAP $XXX Non-GAAP to medical XX, This will value to with $XXX I expected significant range million. membership $XXX stock-based up, growth,
that that by as points other reported basis want in other overall has of core efficiencies. an as is improved have QX or overall basis our We around MA, is details with today our had compared more mean, up XXXX I quarter-over-quarter we points. Vivek this Finally, some to just XXX MCR reported basis the to the In MCR contrast, most public than expected highlights GAAP, average that and reverting XX XXX QX have believe minus will now plus reverting our MCR who and mean. our MA reiterate provide change to markets. to market companies New operating variability approximately points on Jersey